Drug Database
Back to search

United States· US:45802-580_d334a21d-7546-477f-a66a-f95b2cf523ce

Scopolamine Transdermal System

A scopolamine product containing scopolamine, registered in United States by Padagis Israel Pharmaceuticals Ltd. The same ATC class is registered in 3 of our 19 countries.

ATC N05CM05US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedScopolamine Transdermal SystemATCN05CM05REGISTER NO.US:45802-580_d334a21d…PACKS LISTED6CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about scopolamineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Scopolamine is registered in 3 of 19 countries.

Countries holding a registration under ATC N05CM05 (scopolamine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 2 of them publish a price we can compare per daily dose
Search scopolamine products by name

Scopolamine · ATC N05CM05

3 / 19 countries

  • Canada
  • Norwayprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
SCOPOLAMINE
Manufacturer
Padagis Israel Pharmaceuticals Ltd
Country
United States (US)
ATC code
N05CM05
ATC class
Scopolamine
Defined daily dose
0.9 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    4580258046
    10 POUCH in 1 CARTON (45802-580-46) / 1 PATCH, EXTENDED RELEASE in 1 POUCH
  • ndc11
    4580258062
    24 POUCH in 1 CARTON (45802-580-62) / 1 PATCH, EXTENDED RELEASE in 1 POUCH
  • ndc11
    4580258084
    4 POUCH in 1 CARTON (45802-580-84) / 1 PATCH, EXTENDED RELEASE in 1 POUCH
  • ndc11
    45802-580-46
  • ndc11
    45802-580-62
  • ndc11
    45802-580-84

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

335 interactions on record for scopolamine.

Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check scopolamine against other medicinesHow interaction checks work

Scopolamine · interactions on record

335 records

  • 7 severe
  • 197 moderate
  • 17 minor
  • 114 info

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • DextropropoxypheneN02AC04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Scopolamine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All scopolamine products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

  • Belgium · Scopolamine Hbr Sterop
  • Germany · Boro-Scopol N, Scopoderm Tts
  • Denmark · Scopoderm
  • Spain · Escopolamina B. Braun
  • Finland · Scopoderm
  • France · Bromhydrate De Scopolamine Renaudin, Scopoderm Tts
  • United Kingdom (Northern Ireland) · Hyoscine Hydrobromide Wockhardt Uk, Hyoscine Martindale Pharma
  • Ireland · Hyoscine Injection Bp Ethypharm, Kwells
  • Iceland · Scopoderm
  • Luxembourg · Scopoderm Tts
  • Malta · Kwells
  • Netherlands · Scopoderm
  • Norway · Scopoderm
  • Sweden · Scopoderm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fd8f1104-0186-4308-9bea-95a45f63dffb
GET /v1/drugs/fd8f1104-0186-4308-9bea-95a45f63dffb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "TRANSDERMAL",
  "source": "ndc",
  "strength": "1",
  "substance": "SCOPOLAMINE",
  "productndc": "45802-580",
  "dosage_form": "PATCH, EXTENDED RELEASE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA078830",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about scopolamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console